Overview
- Researchers at the Max Planck Institute report in Nature Genetics that BRD2 sets up transcription initiation while BRD4 releases paused RNA polymerase II into elongation.
- The team mapped these steps using rapid protein degradation, chemogenomics, and super‑resolution microscopy in mouse embryonic stem cells.
- BRD2 needs histone H4 acetylation placed by the MOF enzyme to bind chromatin, whereas BRD3 and BRD4 remain largely unaffected when MOF is lost.
- BRD2 forms promoter clusters that are required for initiation, shown by near‑total stalling when its clustering region was removed.
- Pan‑BET drugs block the shared bromodomain across the family and hit both steps at once, helping explain mixed trial results and pointing to more selective, BRD2‑ versus BRD4‑focused strategies that still need testing in human cancers.